INTRODUCTION:

In recent years, transdermal drug delivery methods have attracted a lot of attention because of their potential to improve medication bioavailability and patient compliance by avoiding the gastrointestinal tract and first-pass metabolism. Microneedles are a cutting-edge technology among these systems that provide a painless and minimally invasive substitute for conventional medication delivery techniques including oral consumption and hypodermic injections. Microneedles are tiny needles, usually between 50 and 900 micrometers long, that are intended to pierce the stratum corneum, the skin's outermost layer, without getting to the deeper dermal layers' pain receptors ¹. Since the late 1990s, when the idea of using microneedles for transdermal medication administration was originally proposed, a great deal of research has been done to improve their construction, materials, and design². Metals, polymers, and ceramics are just a few of the materials that may be used to create microneedles; each has special benefits in terms of mechanical strength, biocompatibility, and drug loading capacity³. The processes used to fabricate microneedles have also changed, with technologies including 3D printing, micromolding, and photolithography providing exact control over their shapes and sizes⁴. The capacity of microneedles to transport a variety of therapeutic agents, such as tiny molecules, peptides, proteins, and even vaccinations, is one of its main benefits⁵. Because of their adaptability, they may be used for a range of medicinal purposes, including vaccination campaigns and the treatment of chronic illnesses. Furthermore, microneedles may be made to release drugs in a regulated and sustained manner, which would increase their therapeutic effectiveness even further⁶. In order to enable on-demand medication release, recent developments in microneedle technology have also concentrated on integrating smart materials that react to physiological cues, such as pH or temperature.

Microneedles have been shown to be safe and effective in human subjects in clinical trials, underscoring their potential to enhance patient outcomes and lower medical expenses. For example, compared to traditional insulin injections, microneedle patches for insulin administration have demonstrated promise in improving glycemic control in diabetic patients. Similarly, vaccines based on microneedles have been shown to produce strong immune responses with little adverse effects, which makes them a desirable choice for large-scale vaccination programs. Notwithstanding these encouraging advancements, there are still a number of obstacles in the way of microneedle technology's commercialization. Cost-effectiveness, manufacturing scalability, and regulatory barriers are important issues that must be resolved to enable broad adoption. Additionally, more study is required to comprehend the long-term impacts of frequent microneedle use and to create plans for large-scale manufacturing. To sum up, microneedles are a revolutionary development in transdermal drug delivery that provide a convenient, effective, and painless method of administering medications. More research and development in this area might change the medical care landscape and make it more efficient and patient-friendly.

Fig 1. Representation of microneedle vs hypodermic needle

History and Development of Microneedles:

Significant technical developments and rising interest in minimally invasive medical devices have characterized the development of microneedles (MNs).

Early Concepts and Initial Developments:

The notion of utilizing tiny needles for medication administration was originally put out in the 1970s, which is when the concept of microneedles originated ⁷. However, the technology didn't start to take shape until the 1990s, when improvements in microfabrication processes made this possible ⁸. In a groundbreaking study published in 1998, Mark Prausnitz and his colleagues at the Georgia Institute of Technology showed that microneedles could successfully pierce the stratum corneum, the skin's outermost layer, which qualified them for transdermal medication administration¹. This discovery sparked a great deal of study into improving the materials, production processes, and design of microneedles.

Advancements in Materials and Fabrication Techniques:

Because silicon works well with microfabrication techniques, it was initially the main material utilized to make microneedles. Nevertheless, upon skin implantation, silicon microneedles were prone to breaking². This prompted research into other materials, including metals (such as titanium and stainless steel) and polymers, which provided improved biocompatibility and mechanical strength³.

Microneedle technology advanced significantly in the 2000s, leading to the creation of a variety of microneedle types, including coated, solid, hollow, dissolvable, and hydrogel-based microneedles⁴. The usefulness and variety of applications of microneedles were improved by methods such as photolithography, micromolding, and 3D printing, which allowed for exact control over their size and geometries.

Clinical Applications and Commercialization:

In the early 2000s, the first clinical trials using microneedles for medication administration were conducted. These studies showed that microneedles are a safe and effective way to administer insulin, vaccinations, and other medicinal substances. Microneedle patches for influenza vaccinations, for example, shown encouraging outcomes in generating robust immune responses with little adverse effects.

Microneedles have been investigated in recent years for a variety of uses, such as pain relief, cancer therapy, and cosmetic operations. With a number of microneedle patches and devices gaining regulatory approval and going on sale, the commercialization of goods based on microneedles has also accelerated.

Future Perspectives:

With further research aimed at improving their functionality and broadening their range of uses, microneedle technology appears to have a bright future. Future developments include gene therapy microneedles and smart microneedles that react to physiological cues. To enable broad use, however, issues including cost-effectiveness, manufacturing scalability, and regulatory barriers must be resolved.

In summary, the evolution and history of microneedles show a path of constant invention and advancement. Microneedles have the potential to transform medication delivery and medical treatments, making them more effective, painless, and patient-friendly from their first conception to their present uses.

Advantages:

1. Minimally intrusive and painless:

The procedure is painless because microneedles pierce the skin without coming into contact with pain receptors¹.

Compared to conventional hypodermic needles, they are less intrusive².

2. Increased Adherence by Patients:

Patient compliance is enhanced by the medication's painlessness and simplicity of self-administration³.

Appropriate for individuals who are afraid of needles⁴.

3. Better Drug Distribution:

Microneedles improve medication delivery by avoiding the stratum corneum, the skin's outermost layer⁵.

They make it possible for medications to be released gradually and under control.

4. Versatility:

Both macromolecules and small molecules can use it.

Suitable for a variety of medications, such as insulin, vaccinations, and other medicinal substances.

5. Lower Infection Risk:

Because they don't pierce the skin as deeply as conventional needles, there is a lower chance of

infection.

DISADVANTAGES:

1. Restricted Drug Intake: The quantity of medication that may be administered is restricted by the tiny size of microneedles. Unsuitable for medications requiring large dosages.

2. Difficulties in Manufacturing: Expensive and intricate production procedures. Scaling up manufacturing for commercial usage presents challenges.

3. Skin responses: The application site may experience allergic responses or skin irritation. Drug distribution effectiveness may be impacted by variations in skin thickness and characteristics.

4. Obstacles in Regulation: The regulatory approval procedures might be complicated and time-consuming. Standardized criteria for microneedle products are lacking.

5. Stability and Storage: Certain microneedle formulations may necessitate certain storage conditions due to stability concerns.

Applications:

Because they may administer a variety of therapeutic substances in a painless and less intrusive way, microneedles have demonstrated enormous promise in a number of medical applications. Here are some key applications:

1. Vaccine Delivery: Since they are a painless substitute for conventional hypodermic needles, microneedles have been thoroughly investigated for the administration of vaccines. They may improve immune responses by delivering vaccinations straight to the immune cells in the skin. Research has demonstrated that measles and influenza microneedle patches can elicit robust immune responses with little adverse consequences².

2. Insulin Delivery: Microneedles provide a new way to administer insulin to diabetic patients. Compared to traditional insulin injections, microneedle patches can release insulin in a regulated way, increasing glycemic control and patient compliance¹.

3. Cancer Treatment: The direct administration of chemotherapeutic drugs to tumors via microneedles is being investigated. This targeted administration can enhance the therapeutic effectiveness of cancer therapies and lessen systemic negative effects³.

4. Pain Management: Analgesics can be administered using microneedles to treat pain. They provide quick pain relief with fewer adverse effects than oral or injectable painkillers, and they are non-invasive⁴.

5. Cosmetic Applications: Microneedles are utilized in dermatology for aesthetic procedures including scar removal and anti-aging. They can improve the way topical medications like retinoids and hyaluronic acid are delivered, which will improve the texture and look of skin⁵.

6. Hormone Replacement Therapy: Hormones like estrogen and testosterone can be transdermally delivered via microneedles, offering a practical and less intrusive substitute for oral or injectable hormone therapies⁶.

7. Transdermal Delivery of Biologics: Biologics, such as peptides and proteins, which are often difficult to administer orally because they degrade in the gastrointestinal system, can be delivered via microneedles. For chronic diseases that need ongoing care, this application is very helpful⁷.

8. Gene Therapy: The application of microneedles for gene therapy is being investigated in new studies. A possible treatment for genetic problems is provided by microneedles, which can transport nucleic acids like DNA and RNA straight to skin cells⁸.

These uses demonstrate how adaptable and promising microneedles are for enhancing medication administration and patient outcomes in a range of medical specialties^9,10.

Types of Microneedles:

1. Solid Microneedles

Description: Used to create microchannels in the skin through which drugs can be applied.

2. Coated Microneedles

Description: These microneedles are coated with a drug solution that dissolves upon insertion into the skin.

3. Dissolving Microneedles

Description: Made from biodegradable polymers that dissolve and release the drug into the skin.

4. Hollow Microneedles

Description: These microneedles have a hollow bore through which liquid drugs can be injected directly into the skin^11-13.

Marketed Examples of Microneedles:

1. Micron Jet:

A hollow microneedle device created by Nano Pass Technologies, MicronJet is intended for intradermal administration of vaccinations and other drugs.

2. SoluviaTM:

BD (Becton, Dickinson and Company) uses this microneedle device to administer vaccinations, including the influenza vaccine, intradermally.

3. Dermaroller®:

This microneedle device, which is mainly used for cosmetic purposes, may also be modified for transdermal medicine administration.

4. The 3M™ Microstructured Transdermal System (MTS):

It is a device that allows a variety of medications to be delivered via the skin.

5. QtryptaTM from Zosano Pharma:

A microneedle patch that delivers zolmitriptan, a medication used to treat migraines.

Fig 2. Representation of types of microneedles

CONCLUSION:

A revolutionary development in transdermal medication administration, microneedles provide a painless and minimally invasive substitute for conventional techniques. They are a very appealing alternative for patients and healthcare professionals due to their capacity to improve drug bioavailability, avoid first-pass metabolism, and facilitate self-administration. Each of the several varieties of microneedles—solid, coated, dissolving, hollow, and hydrogel-forming—offers special advantages and is appropriate for a range of medical uses. Microneedles have many benefits, but they also have drawbacks, including a small drug load capacity, difficult and expensive manufacturing procedures, and individual differences in skin barrier characteristics. To overcome these obstacles, continuous research and development is needed to improve the design, composition, and production processes of microneedles. In order to reduce the risk of skin infections and other consequences, it is also crucial to make sure that appropriate training and hygiene procedures are followed. A simplified approval procedure is required to enable the launch of new microneedle-based goods into the market, since regulatory obstacles continue to be a major obstacle to the broad use of microneedles.

REFERENCES:

1. Bala M, Abhinay, Sharma N, Dadawal A. A review: microneedle drug delivery. Asian J Res Pharm Sci. 2024; 14(3): 236–242.

2. Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev. 2012; 64(14): 1547–1568.

3. Bachhav R, Bhamare M, Deore R, Bachhav P, Gavali D, Surana K, et al. Microneedle technology for transdermal drug delivery: a comprehensive review. Asian J Pharm Res. 2025; 15(2): 223–226.

5. Kulkarni RR, Phadtare DG. The microneedle patches: an innovative approach. Asian J Pharm Tech. 2015; 5(4): 195–200.

6. Sarella PNK, Valluri S, Vegi S, Vendi VK, Vipparthi AK. Microneedle arrays: advancements, applications and future prospects in pharmaceutical delivery. Asian J Pharm Technol. 2024; 14(3): 229–236.

7. Kumbhar PS, Jadhav TP, Chopade SS, Gavade TT, Sorate RC, Shinde TU, et al. Microneedles: an advanced approach for transdermal delivery of biologics. Asian J Pharm Res. 2021; 11(1): 46–54.

8. Maniyar MM, Deshmukh AS, Shelke SJ. Ethosomes: a carrier for transdermal drug delivery system. Asian J Pharm Res. 2022; 12(3): 225–228.

9. Wu J. Microneedles: applications and devices. In: Li D, editor. Encyclopedia of Microfluidics and Nanofluidics. New York: Springer; 2014. p. 1–9.

10. More S, Ghadge T, Dhole S. Microneedle: an advanced technique in transdermal drug delivery system. Asian J Res Pharm Sci. 2013; 3(3): 141–148.

11. Henry S, McAllister DV, Allen MG, Prausnitz MR. Microfabricated microneedles: a novel approach to transdermal drug delivery. J Pharm Sci. 1998; 87(8): 922–925.

12. Sharma N, Sharma TK, Pandit V, Ashawat MS. A smart and potential approach for transdermal drug delivery using microneedles: a review. Asian J Res Pharm Sci. 2021; 11(2): 113–120.

13. Sirisha Y, Sriram B, Sri RS. Formulation development and evaluation of Nifedipine-loaded ethosomal gel for transdermal drug delivery. Asian J Pharm Res. 2023; 13(2): 77–80.

14. Mehetar M, Darekar S. Microneedles: a pharmaceutical review. Asian J Pharm Technol. 2023; 13(2): 146–154.

Received on 10.09.2025 Revised on 19.12.2025

Accepted on 09.02.2026 Published on 06.07.2026

Available online from July 20, 2026

Asian J. Pharm. Res. 2026; 16(3):320-324.

DOI: 10.52711/2231-5691.2026.00047

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Creative Commons License.